The monoclonal antibodies treatment that was introduced in India a few weeks ago is already being used successfully to treat some high risk patients, leading to doctors describing it as a game-changer. This treatment helps avoid hospitalisation in a high-risk group and progression to severe disease. It can also help in escaping or reducing the usage of steroids.